IP Library Granted Patent US 9,447,295
Granted Patent B2
US 9,447,295 · App. 14/910,965 · Granted Sep 20, 2016

Ink-jet printing ink comprising N-vinyloxazolidinone

Inventors: Erhard Guenther (Hassloch, DE); Radwan Abdallah (Ludwigshafen, DE); Giovanni Dandola (Heidelberg, DE); Dagmar Pascale Kunsmann-Keitel (Limburgerhof, DE); Edouard Loisel (Leimen, DE)
Assignee: BASF SE
C09D11/101B41J11/002C09D11/106C09D11/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,447,295
App. No.
14/910,965
Granted
Sep 20, 2016
Kind
B2
Abstract

Use of a radiation curable composition as printing ink for ink-jet printing, wherein the radiation curable composition comprises N-vinyloxazolidinone of formula (I) in which R 1 to R 4 independently from each other are a hydrogen atom or an organic radical having not more than 10 carbon atoms.

Claims (16)

1. A process, comprising applying a printing ink to a substrate and exposing the printing ink to an energy to form a coated substrate, wherein the printing ink comprises a radiation curable composition comprising an N-vinyloxazolidinone of formula (I):

in which R 1 to R 4 independently from each other are a hydrogen atom or an organic radical having not more than 10 carbon atoms.

2. The process of claim 1 , wherein at least two of R 1 to R 4 are a hydrogen atom and any remaining R 1 to R 4 are an organic radical having not more than 10 carbon atoms.

3. The process of claim 1 , wherein:

all of R 1 to R 4 are hydrogens,

R 1 is a C1 to C4 alkyl group, and R 2 to R 4 are hydrogens, or

R 1 and R 2 are hydrogens, and R 3 and R 4 are independently a C1 to C4 alkyl group.

4. The process of claim 1 , wherein the radiation curable composition comprises the N-vinyloxazolidinone in an amount of from 0.5 to 80% by weight.

5. The process of claim 1 , wherein the radiation curable composition further comprises a (meth)acryloyl compound comprising at least one (meth)acryloyl group.

6. The process of claim 5 , wherein the radiation curable composition comprises at least one (meth)acryloyl compound having two to five (meth)acryloyl groups.

7. The process of claim 5 , wherein at least 70% by weight of all radiation curable compounds of the radiation curable composition are (meth)acryloyl compounds and the N-vinyloxazolidinone.

8. The process of claim 1 , wherein the radiation curable composition comprises less than 10% by weight of ater or organic solvents.

9. The process of claim 1 , wherein the radiation curable composition comprises at least one photoinitiator.

10. The process of claim 1 , wherein the process is an ink jet printing process.

11. The process of claim 10 , wherein the radiation curable composition is printed on a substrate and subsequently cured by radiation.

12. The process of claim 10 , wherein the substrate is a polypropylene substrate.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 12, 2016
From: GUENTHER, ERHARD; ABDALLAH, RADWAN; DANDOLA, GIOVANNI; KUNSMANN-KEITEL, DAGMAR PASCALE; LOISEL, EDOUARD
To: BASF SE
Reel/Frame 037721/0920 →
Priority Claims (1)
EP 13180035.1 · Aug 12, 2013 · regional
Continuity (1)
Related Publication 20160193852A1 · Jul 7, 2016